.Pharmacolibrary.Drugs.ATC.N.N04BC07 .Pharmacolibrary.Drugs.ATC.N.N04BC07| name: | Apomorphine |
| ATC code: | N04BC07 | route: | subcutaneous |
| n-compartments | 2 |
Apomorphine is a non-ergoline dopamine agonist used mainly in the management of advanced Parkinson's disease to reduce off episodes. It is administered subcutaneously, often as a rescue therapy for sudden motor fluctuations. Apomorphine is currently approved and in clinical use for this indication.
Pharmacokinetic parameters for healthy adult volunteers and Parkinson's disease patients after subcutaneous administration.
Agbo, F, et al., & Navia, B (2021). Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson's disease. Clinical and translational science 14(4) 1464–1475. DOI:10.1111/cts.13008 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33650272
Neef, C, & van Laar, T (1999). Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease. Clinical pharmacokinetics 37(3) 257–271. DOI:10.2165/00003088-199937030-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10511920
Briganti, A, et al., & Montorsi, F (2006). A comparative review of apomorphine formulations for erectile dysfunction : recommendations for use in the elderly. Drugs & aging 23(4) 309–319. DOI:10.2165/00002512-200623040-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16732690